NCT04860570

Brief Summary

This study aims to evaluate the utility of double-ring wound-edge protectors to prevent the development of superficial surgical site infections after open appendectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
671

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 27, 2021

Completed
3.5 years until next milestone

Study Start

First participant enrolled

October 25, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

December 7, 2023

Status Verified

December 1, 2023

Enrollment Period

2 months

First QC Date

April 22, 2021

Last Update Submit

December 6, 2023

Conditions

Keywords

Acute appendicitisdouble-ring wound-edge protectorsuperficial surgical site infection

Outcome Measures

Primary Outcomes (1)

  • Superficial surgical site infection (sSSI)

    To compare the incidence of sSSI in both groups (OA+2RWEP versus LA) during postoperative period to determine wether 2RWEP are useful in reducing sSSI after open appendectomy.

    30 days after surgery

Secondary Outcomes (2)

  • Organ-space surgical site infection (oeSSI)

    30 days

  • Hospital stay

    30 days

Study Arms (2)

Open Appendectomy (OA) + Double-ring wound-edge protector (2RWEP)

Intervention group: Patients with diagnosis of acute appendicitis treated by open appendectomy using a double-ring wound-edge protector.

Device: Double-ring wound-edge protector

Laparoscopic Appendectomy (LA)

Control group: Patients with diagnosis of acute appendicitis treated by laparoscopic appendectomy.

Interventions

Double-ring wound-edge protector: Alexis Applied Medical ®, Rancho Santa Margarita, California.

Open Appendectomy (OA) + Double-ring wound-edge protector (2RWEP)

Eligibility Criteria

Age15 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients 15 years old or older, with diagnosis of acute appendicitis who were treated either by open appendectomy using a double-ring wound-edge protector or by laparoscopic appendectomy at Hospital Recoletas Campo Grande de Valladolid and Hospital Comarcal de Medina del Campo.

You may qualify if:

  • Age of at least 15 years old.
  • Clinical diagnosis of acute appendicitis.
  • Treated by: Open appendectomy + double-ring wound-edge protector or Laparoscopic appendectomy.
  • Note: with the aim of avoiding selection bias, all patients presenting risk factors for surgical site infections (eg obesity, diabetes, malnourishment, immunosupression, etc.) will be included in the present study.

You may not qualify if:

  • Patients who did not receive prophylactic antibiotic.
  • Source of abdominal pathology other than the caecal appendix.
  • Follow-up period less than 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Comarcal de Medina del Campo

Medina del Campo, 47400, Spain

RECRUITING

MeSH Terms

Conditions

AppendicitisSurgical Wound Infection

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal DiseasesWound InfectionPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Johnn Henry Herrera Kok

    Complejo Asistencial Universitario de León, Spain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Johnn Henry Herrera Kok, MD

CONTACT

Juan Carlos Martín Del Olmo, MD, phD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Johnn Henry Herrera Kok

Study Record Dates

First Submitted

April 22, 2021

First Posted

April 27, 2021

Study Start

October 25, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

December 7, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations